Moderator
Amanda Cole, BSc, PhD, Office of Health Economics, London, United Kingdom
Speakers
James Koh, BA, MSc, PhD, NICE, Manchester, United Kingdom; Ankur Pandya, MPH, PhD, Harvard T.H. Chan School of Public Health, Boston, MA, United States
As health systems confront rising costs and widening inequalities, decision-makers must look beyond how much benefit an intervention delivers to consider who benefits.
The Health Science Policy Council's Spotlight session provides a critical evaluation of distributional cost-effectiveness analysis (DCEA) as a framework for quantitatively embedding equity into value assessment. Dr Ankur Pandya will introduce the Threshold Inequality Aversion Parameter (TIAP), a methodological advance that identifies the point at which society’s preference for fairness justifies choosing a more equitable—even if less efficient—option. James Koh will provide a critique of the TIAP method and DCEA in general from a policy perspective. The session will examine methodological challenges, data requirements, remaining normative issues, and practical implications of the approach.
For DCEA enthusiasts and sceptics alike, this session offers timely and candid perspectives on equity methods for value assessment and their place in decision making.
Topic
Economic Evaluation, Health Technology Assessment, Methodological & Statistical Research